Velarion Records
Free. Unsubscribe any time.

Theravance Biopharma, Inc. (TBPH)

Theravance Biopharma, Inc. filed 10 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 23 transactions and 250,949 shares. None carries the SEC's AFF10B5ONE flag; all 10 name a plan in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in Theravance Biopharma, Inc. 23

Adoption dates in Theravance Biopharma, Inc. 1

Results prints in Theravance Biopharma, Inc. 8

Trades before a print in Theravance Biopharma, Inc. 3

Interval to Theravance Biopharma, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Theravance Biopharma, Inc. states

Filing text: “10b5-1 trading plan adopted on March 14, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.

The address of this record

Theravance Biopharma, Inc.’s insider trading plan record — 10 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001583107.